Kevin Lee, Bicycle Therapeutics CEO

Bi­cy­cle Ther­a­peu­tics stock sinks fol­low­ing re­lease of topline da­ta, post-hoc analy­ses

Bi­cy­cle Ther­a­peu­tics shared sev­er­al batch­es of da­ta for its bi­cyclic tox­in con­ju­gate in metasta­t­ic urothe­lial can­cer, non-small cell lung can­cer and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.